These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25041493)

  • 21. Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists.
    Sun GY; Xu J; Jensen MD; Yu S; Wood WG; González FA; Simonyi A; Sun AY; Weisman GA
    Mol Neurobiol; 2005; 31(1-3):27-41. PubMed ID: 15953810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asthenozoospermia and membrane remodeling enzymes: a new role for phospholipase A2.
    Anfuso CD; Olivieri M; Bellanca S; Salmeri M; Motta C; Scalia M; Satriano C; La Vignera S; Burrello N; Caporarello N; Lupo G; Calogero AE
    Andrology; 2015 Nov; 3(6):1173-82. PubMed ID: 26446356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of brain membranes in schizophrenia: impact of phospholipase A(2).
    Schaeffer EL; Gattaz WF; Eckert GP
    Curr Top Med Chem; 2012; 12(21):2314-23. PubMed ID: 23279172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A
    Nikolaou A; Kokotou MG; Vasilakaki S; Kokotos G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):941-956. PubMed ID: 30905350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity.
    Ross BM; Moszczynska A; Erlich J; Kish SJ
    J Neurochem; 1998 Feb; 70(2):786-93. PubMed ID: 9453575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rat ovarian phospholipase A2 system: gene expression, cellular localization, activity characterization, and interleukin-1 dependence.
    Kol S; Ruutiainen-Altman K; Ben-Shlomo I; Payne DW; Ando M; Adashi EY
    Endocrinology; 1997 Jan; 138(1):322-31. PubMed ID: 8977420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
    Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
    Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrete roles of intracellular phospholipases A2 in human neutrophil cytotoxicity.
    Mikami S; Aiboshi J; Kobayashi T; Kojima M; Morishita K; Otomo Y
    J Trauma Acute Care Surg; 2015 Aug; 79(2):238-46. PubMed ID: 26218692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia.
    Muralikrishna Adibhatla R; Hatcher JF
    Free Radic Biol Med; 2006 Feb; 40(3):376-87. PubMed ID: 16443152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipase A2 structure/function, mechanism, and signaling.
    Burke JE; Dennis EA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S237-42. PubMed ID: 19011112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated PLA2 activity in schizophrenics and other psychiatric patients.
    Noponen M; Sanfilipo M; Samanich K; Ryer H; Ko G; Angrist B; Wolkin A; Duncan E; Rotrosen J
    Biol Psychiatry; 1993 Nov; 34(9):641-9. PubMed ID: 8292693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipase A2 (PLA2) activity in gerbil brain: characterization of cytosolic and membrane-associated forms and effects of ischemia and reperfusion on enzymatic activity.
    Bonventre JV; Koroshetz WJ
    J Lipid Mediat; 1993; 6(1-3):457-71. PubMed ID: 8358004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.
    Stephenson DT; Lemere CA; Selkoe DJ; Clemens JA
    Neurobiol Dis; 1996 Feb; 3(1):51-63. PubMed ID: 9173912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia].
    Gattaz WF; Nevalainen TJ; Kinnunen PK
    Fortschr Neurol Psychiatr; 1990 Apr; 58(4):148-53. PubMed ID: 2354835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.
    Smesny S; Kinder D; Willhardt I; Rosburg T; Lasch J; Berger G; Sauer H
    Biol Psychiatry; 2005 Feb; 57(4):399-405. PubMed ID: 15705356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids.
    Green JT; Orr SK; Bazinet RP
    J Lipid Res; 2008 May; 49(5):939-44. PubMed ID: 18252846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.
    Gattaz WF; Köllisch M; Thuren T; Virtanen JA; Kinnunen PK
    Biol Psychiatry; 1987 Apr; 22(4):421-6. PubMed ID: 3567258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased phospholipase A2 activity in Alzheimer brains.
    Gattaz WF; Maras A; Cairns NJ; Levy R; Förstl H
    Biol Psychiatry; 1995 Jan; 37(1):13-7. PubMed ID: 7893853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.
    Schaeffer EL; Forlenza OV; Gattaz WF
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):37-51. PubMed ID: 18853146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.